Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study
January 1, 2024
Related Stories
No related posts.
You’re leaving the 澳门正规博彩十大排行平台 website.
Links to sites outside of this website are provided as a resource to the viewer. 澳门正规博彩十大排行平台 accepts no responsibility for the content of linked sites.
